A potassium channel opener is a type of drug which facilitates ion transmission through potassium channels.
Some examples include:
6T & 1P
2T & 1P
4T & 2P
XEN1101 is a novel positive allosteric modulator ("opener") of the potassium channel KCNQ2/3 (Kv7.2/7.3) currently being developed by Xenon Pharmaceuticals Inc. for the treatment of focal epilepsy.
This pharmacology-related article is a stub. You can help Wikipedia by expanding it.
Lokasi Pengunjung: 3.145.10.45